Characterization of acute renal allograft rejection by human serum proteomic analysis. 2009

Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education, Ministry of Health, Wuhan, 430030, China. gaotongji@163.com

To identify acute renal allograft rejection biomarkers in human serum, two-dimensional differential in-gel electrophoresis (2-D DIGE) and reversed phase high-performance liquid chromatography (RP-HPLC) followed by electrospray ionization mass spectrometry (ESI-MS) were used. Serum samples from renal allograft patients and normal volunteers were divided into three groups: acute rejection (AR), stable renal function (SRF) and normal volunteer (N). Serum samples were firstly processed using Multiple Affinity Removal Column to selectively remove the highest abundance proteins. Differentially expressed proteins were analyzed using 2-D DIGE. These differential protein spots were excised, digested by trypsin, and identified by RP-HPLC-ESI/MS. Twenty-two differentially expressed proteins were identified in serum from AR group. These proteins included complement C9 precursor, apolipoprotein A-IV precursor, vitamin D-binding protein precursor, beta-2-glycoprotein 1 precursor, etc. Vitamin D-binding protein, one of these proteins, was confirmed by ELISA in the independent set of serum samples. In conclusion, the differentially expressed proteins as serum biomarker candidates may provide the basis of acute rejection noninvasive diagnosis. Confirmed vitamin D-binding protein may be one of serum biomarkers of acute rejection. Furthermore, it may provide great insights into understanding the mechanisms and potential treatment strategy of acute rejection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014809 Vitamin D-Binding Protein An alpha-globulin found in the plasma of man and other vertebrates. It is apparently synthesized in the liver and carries vitamin D and its metabolites through the circulation and mediates the response of tissue. It is also known as group-specific component (Gc). Gc subtypes are used to determine specific phenotypes and gene frequencies. These data are employed in the classification of population groups, paternity investigations, and in forensic medicine. Group-Specific Component Globulin,Vitamin D-Binding Globulin,25-HCC-Binding Protein,25-Hydroxycholecalciferol-Binding Protein,25-Hydroxyvitamin D-Binding Protein,Calciferol-Binding Protein,Gc Globulin,Transcalciferin,25 HCC Binding Protein,25 Hydroxycholecalciferol Binding Protein,25 Hydroxyvitamin D Binding Protein,Calciferol Binding Protein,Component Globulin, Group-Specific,Globulin, Gc,Globulin, Group-Specific Component,Globulin, Vitamin D-Binding,Group Specific Component Globulin,Vitamin D Binding Globulin,Vitamin D Binding Protein
D015180 Electrophoresis, Gel, Two-Dimensional Electrophoresis in which a second perpendicular electrophoretic transport is performed on the separate components resulting from the first electrophoresis. This technique is usually performed on polyacrylamide gels. Gel Electrophoresis, Two-Dimensional,Polyacrylamide Gel Electrophoresis, Two-Dimensional,2-D Gel Electrophoresis,2-D Polyacrylamide Gel Electrophoresis,2D Gel Electrophoresis,2D PAGE,2D Polyacrylamide Gel Electrophoresis,Electrophoresis, Gel, 2-D,Electrophoresis, Gel, 2D,Electrophoresis, Gel, Two Dimensional,Polyacrylamide Gel Electrophoresis, 2-D,Polyacrylamide Gel Electrophoresis, 2D,Two Dimensional Gel Electrophoresis,2 D Gel Electrophoresis,2 D Polyacrylamide Gel Electrophoresis,Electrophoresis, 2-D Gel,Electrophoresis, 2D Gel,Electrophoresis, Two-Dimensional Gel,Gel Electrophoresis, 2-D,Gel Electrophoresis, 2D,Gel Electrophoresis, Two Dimensional,PAGE, 2D,Polyacrylamide Gel Electrophoresis, 2 D,Polyacrylamide Gel Electrophoresis, Two Dimensional,Two-Dimensional Gel Electrophoresis

Related Publications

Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
May 2003, Annals of surgery,
Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
February 2012, Molecular biology reports,
Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
January 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
July 2014, Shock (Augusta, Ga.),
Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
June 2009, Proteomics. Clinical applications,
Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
September 2010, Molecular & cellular proteomics : MCP,
Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
December 2011, Zhonghua yi xue za zhi,
Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
March 2024, International journal of molecular sciences,
Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
August 2009, Transplantation,
Ying Gao, and Ke Wu, and Yi Xu, and Hongmin Zhou, and Wentao He, and Weina Zhang, and Lanjun Cai, and Xingguang Lin, and Zemin Fang, and Zhenlong Luo, and Hui Guo, and Zhonghua Chen
January 1971, Proceedings of the Clinical Dialysis and Transplant Forum,
Copied contents to your clipboard!